Persistent Hyperplastic Primary Vitreous
Showing 1 - 25 of >10,000
Osteoarthritis, Knee, Rheumatoid Arthritis, Knee, Spontaneous Osteonecrosis of Knee Trial (Prepectoral, Subpectoral)
Not yet recruiting
- Osteoarthritis, Knee
- +2 more
- Prepectoral
- Subpectoral
- (no location specified)
Nov 10, 2023
Spontaneous Vitreous Hemorrhage, Retinal Break, Retinal Detachment Trial in Paris (Early vitrectomy)
Recruiting
- Spontaneous Vitreous Hemorrhage
- +2 more
- Early vitrectomy
-
Paris, Ile De France, FranceHopital Lariboisiere
Nov 21, 2022
Weiss Ring Trial in Dongyang (YAG vitreolysis)
Recruiting
- Weiss Ring
- YAG vitreolysis
-
Dongyang, Zhejiang, ChinaDongyang People's Hospital
Apr 4, 2023
Diabetic Macular Edema Trial (Bevacizumab Injection [Avastin] (IVB-I), Triamcinolone Acetonide 10mg/mL (IVT-II), Bevacizumab
Completed
- Diabetic Macular Edema
- Bevacizumab Injection [Avastin] (IVB-I)
- +2 more
- (no location specified)
May 24, 2022
Persistent Fetal Vasculature, Congenital Cataract Trial in Wenzhou (cataract surgery cataract extraction and intraocular
Unknown status
- Persistent Fetal Vasculature
- Congenital Cataract
- cataract surgery cataract extraction and intraocular implantation
-
Wenzhou, Zhejiang, ChinaEye Hospital of Wenzhou Medical College
Nov 9, 2017
Right Colon Adenoma Miss Rate, Right Colon Hyperplastic Polyp Miss Rate Trial in Taoyuan (Colon Polypectomy)
Recruiting
- Right Colon Adenoma Miss Rate
- Right Colon Hyperplastic Polyp Miss Rate
- Colon Polypectomy
-
Taoyuan, TaiwanEvergreen General Hospital
Aug 5, 2022
Ovarian Carcinoma Trial in New Haven (Sacituzumab govitecan)
Not yet recruiting
- Ovarian Carcinoma
- Sacituzumab govitecan
-
New Haven, ConnecticutSmilow Cancer Hospital at Yale New Haven
Aug 31, 2023
Bilateral Retinoblastoma, Childhood Intraocular Retinoblastoma, Unilateral Retinoblastoma Trial (Biospecimen Collection,
Not yet recruiting
- Bilateral Retinoblastoma
- +2 more
- Biospecimen Collection
- +6 more
- (no location specified)
Aug 17, 2022
Vascular Structure, Vascular Function and Vascular Aging in
Recruiting
- Persistent COVID-19
- +3 more
-
Salamanca, SpainPrimary Care Research Unit of Salamanca (APISAL)
Apr 18, 2023
Proliferative Diabetic Retinopathy Trial in Montemorelos (vitrectomy with sulfur hexafluoride gas, vitrectomy with balanced salt
Active, not recruiting
- Proliferative Diabetic Retinopathy
- vitrectomy with sulfur hexafluoride gas
- vitrectomy with balanced salt solution
-
Montemorelos, Nuevo Leon, MexicoLa Carlota Hospital
Nov 20, 2021
MRD-tailored Therapy in Newly Diagnosed Multiple Myeloma With
Not yet recruiting
- Multiple Myeloma
- Minimal Residual Disease
- (no location specified)
Nov 1, 2023
Floaters, Vitreous Opacities Trial in Panama city (SVO-ID)
Not yet recruiting
- Floaters
- Vitreous Opacities
- SVO-ID
-
Panama city, PanamaPanama Eye Center
Oct 19, 2023
Intravitreal Aqueous Tamponade on Lens Status and Ocular
Completed
- Aqueous Tamponade
- Cataract
- pars plana vitrectomy
-
Changchun, ChinaThe Second Hospital of Jilin University
Nov 10, 2023
Vitamin C, COVID-19 Pneumonia Trial in China (Vitamin C, Placebo)
Recruiting
- Vitamin C
- COVID-19 Pneumonia
- Vitamin C
- Placebo
-
Guanzhou, Guangdong, China
- +3 more
Jan 19, 2023
SOX17 and E-Cadherin in Variable Endometrial Lesions
Not yet recruiting
- Variable Endometrial Lesions
-
Sohag, EgyptSohag faculty of Medicine
Nov 9, 2023
Related to Chronic Cough After Pulmonary Resection
Recruiting
- Persistent Cough
- +2 more
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Oct 16, 2022
Diabetic Retinopathy, Postoperative Recurrent Vitreous Hemorrhage, Pars Plana Vitrectomy Trial in Tianjin (Ranibizumab
Recruiting
- Diabetic Retinopathy
- +3 more
- Ranibizumab Injection
- PPV
-
Tianjin, Tianjin, ChinaTianjin medical university eye hosipital
Aug 11, 2022
Retinal Detachment, Proliferative Vitreoretinopathy Trial (Control group, Intervention group)
Not yet recruiting
- Retinal Detachment
- Proliferative Vitreoretinopathy
- Control group
- Intervention group
- (no location specified)
Sep 9, 2022
Asthma Trial in Canada, United States (TEV-53275 Dose A, TEV-53275 Dose B, Placebo)
Terminated
- Asthma
- TEV-53275 Dose A
- +2 more
-
Hoover, Alabama
- +81 more
Dec 27, 2022
Sleep Initiation and Maintenance Disorders Trial in Korea, Republic of (Lemborexant, PBO)
Recruiting
- Sleep Initiation and Maintenance Disorders
- Lemborexant
- PBO
-
Seongnam-si, Gyeonggi-do, Korea, Republic of
- +8 more
Dec 20, 2022
Neurotrophic Keratitis Trial in United States (rhNGF 20µg/ml, Placebo)
Completed
- Neurotrophic Keratitis
- rhNGF 20µg/ml
- Placebo
-
Loma Linda, California
- +11 more
Mar 31, 2022
Pain, Chronic Trial (Empowered Relief)
Not yet recruiting
- Pain, Chronic
- Empowered Relief
- (no location specified)
Jun 27, 2023
Primary Immune Thrombocytopenia Trial in Worldwide (PF-06835375)
Suspended
- Primary Immune Thrombocytopenia
- PF-06835375
-
Jacksonville, Florida
- +27 more
Jan 25, 2023
Persistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation Trial in Ljubljana (Pulse field ablation,
Enrolling by invitation
- Persistent Atrial Fibrillation
- Longstanding Persistent Atrial Fibrillation
- Pulse field ablation
- Radiofrequency ablation
-
Ljubljana, SloveniaCardiovascular Surgery Department, University Medical Centre Lju
Nov 19, 2023